Br J Ophthalmol 1999;83:501 ( April )
Letters to the editor
Ochrobactrum anthropi
endophthalmitis after vitreous surgery
EDITOR, Ochrobactrum
anthropi is a non-fermentative, motile, strictly aerobic,
oxidase positive Gram negative bacillus.1 In 1980, the
first case of human infection with O
anthropi was described.2 Since then, there have
been some reports and this bacillus has been considered as a possible
cause of opportunistic infection. There are only two reports of
O anthropi endophthalmitis, one was
metastatic endophthalmitis in a patient with a central venous
catheter,3 and the other was after cataract
surgery.4 We describe a case of unilateral endophthalmitis
caused by O anthropi, which was diagnosed
after two vitreous surgery procedures.
CASE REPORT
A 64 year old man complained of visual loss in his left eye in January
1998. He was diagnosed with uveitis and treated with oral prednisolone,
topical betamethasone and atropine, and subconjunctival injection of
dexamethasone. As the inflammation had not resolved, he was transferred
to our institution. He had a medical history of bacterial endocarditis
caused by Streptococcus haemolyticus in
April 1997 and underwent placement of a central venous catheter for 1 month. Mitral valvuloplasty had been performed in October 1997.
His visual acuity was right eye 20/20 and left eye 20/100. The left eye
had anterior chamber inflammation with flare (1+) and cells (2+),
keratic precipitates, and prominent vitritis with a lobulated white
mass. The right eye was normal. A clinical diagnosis of fungal
endophthalmitis was made in the left eye. Medication was changed to
intravenous fluconazole, topical betamethasone, and subconjunctival
injection of dexamethasone, but vitreous haze was still present with
this treatment (Fig 1). A pars plana vitrectomy with removal of the
lens and intravitreal fluconazole irrigation was performed on 14 April
1998. The next day he had severe pain in his left eye and headache.
Left visual acuity reduced to light perception, intraocular
pressure was 42 mm Hg, and marked inflammation with hypopyon was
observed. As a bacterial endophthalmitis was suspected, he underwent
the second vitrectomy on 16 April 1998 with intravitreal imipenem
irrigation. Vitreous cultures grew O
anthropi. The isolate was sensitive to cefmetazole,
cefbuperazone, imipenem, minocycline, levofloxacin, gentamicin,
tobramycin, and amikacin, and resistant to ampicillin, piperacillin,
cefazolin, cefotiam, flomoxef, and ceftazidime. He was treated with
intravenous imipenem, oral minocycline, and ciprofloxacin,
successively, and the intraocular inflammation subsided. Four months
after the second vitrectomy, his left visual acuity was
20/30.
COMMENT
The natural habitat of O anthropi has not
yet been established. It is commonly found in environmental and
hospital water sources.1 2 This organism has been
isolated from clinical specimens, including blood, urine, faeces, and
sputum. Most cases of O anthropi sepsis were
reported to relate to indwelling catheters for venous access or other
permanent medical devices.5-7 As for the infectious routes, there are two possibilities in our case. One is contamination during mitral valvuloplasty. Indeed, a lobulated white mass in the
vitreous seen before the first vitrectomy (Fig 1) is similar to that in
the case of Berman et al.3 In
the past, however, O anthropi
endophthalmitis occurred within 3 weeks after placement of a central
venous catheter.3 Endophthalmitis occurred in our case
more than 70 days after the mitral valvuloplasty. Moreover, O anthropi was detected from in the vitreous
sample only at the second vitreous procedure. Accordingly,
contamination in our case may have been caused during the first
vitreous surgery procedure. Bacterial endophthalmitis after vitreous
surgery is very rare; its frequency is about 0.2%.8 9
The main organisms causing endophthalmitis are
Pseudomonas aeruginosa,
Staphylococcus epidermidis, and
S aureus.8 9 However, one
should look out for infections induced by attenuated bacteria such as
O anthropi after vitrectomy.
KENJI INOUE, JIRO NUMAGA, YOICHI NAGATA, MASAHIKO SAKURAI, NATSUE ASO, YUJIRO FUJINO Department of Ophthalmology, Branch Hospital, Faculty of
Medicine, University of Tokyo
Correspondence to: Kenji Inoue, Department of
Ophthalmology, Branch Hospital, Faculty of Medicine, University of
Tokyo, 3-28-6, Mejirodai, Bunkyo-ku, Tokyo 112-8688, Japan.
Accepted for publication 22 October 1998
References
| 1.
|
Holmes B,
Popoff M,
Kiredjian M,
et al. Ochrobactrum anthropi gen nov, sp nov from human clinical specimens and previously known as group Vd.
Int J Syst Bacteriol
1988;38:406-416[Abstract/Free Full Text].
|
| 2.
|
Appelbaum PC,
Campbell DB. Pancreatic abscess associated with Achromobacter group Vd biovar 1.
J Clin Microbiol
1980;12:282-283[Abstract/Free Full Text].
|
| 3.
|
Berman AJ,
Del Priore LV,
Fischer CK. Endogenous Ochrobactrum anthropi endophthalmitis.
Am J Ophthalmol
1997;123:560-562[Medline].
|
| 4.
|
Braun M,
Jonas JB,
Sch nherr U,
et al. Ochrobactrum anthropi endophthalmitis after uncomplicated cataract surgery.
Am J Ophthalmol
1996;122:272-273[Medline].
|
| 5.
|
Gill MV,
Ly H,
Mueenuddin M,
et al. Intravenous line infection due to Ochrobactrum anthropi (CDC Group Vd) in a normal host.
Heart Lung
1997;26:335-336[Medline].
|
| 6.
|
Cieslak TJ,
Drabick CJ,
Robb ML. Pyogenic infections due to Ochrobactrum anthropi.
Clin Infect Dis
1996;22:845[Medline]t7.
|
| 7.
|
Gransden WR,
Eykyn SJ. Seven cases of bacteremia due to Ochrobactrum anthropi.
Clin Infect Dis
1992;15:1068-1069[Medline].
|
| 8.
|
Ho PC,
Tolentino FI. Bacterial endophthalmitis after closed vitrectomy.
Arch Ophthalmol
1984;102:207-210[Abstract].
|
| 9.
|
Blankenship GW. Endophthalmitis after pars plana vitrectomy.
Am J Ophthalmol
1977;84:815-817[Medline].
|
© 1999 by British Journal of Ophthalmology
|
|